Episode 1: We have a problem

September 12, 2019

Listen Now: The Etherist Podcast – Episode 1: We Have A Problem. Featuring, among others, our Yoram Unguru discussing drug shortages in pediatric oncology

Quick Read

The cannabis compound known as CBD is being touted as a treatment for a variety of conditions. But the substance’s uncertain legal status is stalling serious investigation

Quick Read

Evidence-based medicine has made progress since doctors’ infamous bloodletting of George Washington, but less than you might think

Quick Read

For years, American smokers have been spared the unpleasant images of gangrene infected feet, swollen tongues overtaken by cancerous tumors and blackened lungs that are often plastered onto packs of cigarettes sold around the world. But that momentary reprieve before lighting up may only last a few more years

Quick Read

The company acts after FDA reports increased illnesses and deaths linked to its devices

Quick Read

The FDA almost never tests products itself. But in May, JAMA published the results of a randomized trial, conducted by FDA researchers, to determine whether the chemicals in four commercially available sunscreens are absorbed through the skin into the bloodstream

Quick Read

After a two-year stint running the Food and Drug Administration, Scott Gottlieb has joined the board of directors at Pfizer, giving the world’s largest drug maker crucial insights into the inner workings of the Trump administration as it attempts to contain national angst over the rising cost of medicines

Quick Read

It’s launching their physicians into uncharted territory. Corner-store cannabidiol “scares the bejesus” out of Dr. Jacqueline French. French, a neurologist, tries to steer her patients away from sprinting to the neighborhood bodega to buy versions of the hemp derivative that’s better known as CBD

Quick Read